Morning Watchlist

    Three Small-Caps That Caught Billionaire Attention - 3/9

    Ian Cooper
    Monday, March 9, 20267 min read
    Three Small-Caps That Caught Billionaire Attention - 3/9

    6 Billionaires Bought Small-Caps. Here Are 3 Names Worth Watching.

    There’s a reason investors track billionaire portfolios.

    And when multiple well-known managers start circling the same small-cap names, it can be a useful signal — not because billionaires are magicians, but because they tend to have better access, deeper research benches, and more patience than the average investor.

    That doesn’t mean you should blindly copy every 13F filing.

    It does mean you should pay attention when several smart operators end up in the same neighborhood.

    Because that usually tells you one of three things: the market is missing a catalyst, mispricing a business, or ignoring a niche that could get a lot more interesting in a hurry.

    The overlooked compounder: SiteOne sells the boring stuff that keeps showing up in demand

    SiteOne fits the second bucket.

    That may sound sleepy.

    Because this is the kind of business they often love: category leadership, a consolidator in a fragmented industry, recurring end-market demand, and room for operating leverage if the cycle improves.

    It’s a slow grinder.

    And sometimes slow grinders beat flashy stories because they don’t need perfection to work.

    If housing activity stabilizes, if contractor demand improves, or if SiteOne keeps rolling up smaller operators intelligently, this kind of name can quietly rerate higher while nobody on financial TV is talking about it.

    Advantage Gold

    Jason Hanson spent years operating in places where currencies collapsed overnight and banks couldn't be trusted. The one thing that kept people safe? Precious metals — and knowing exactly how to hide, move, and multiply them. In Operation Gold Rush, he's sharing those classified-level strategies for the first time. And right now, partnered with Advantage Gold — America's #1 rated precious metals firm — he's giving the book away free.

    The new public-market name: Medline gives you scale, supplies, and a fresh IPO story

    Supply Chain Solutions — and serves hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes in the United States and internationally. Its product lineup spans surgical solutions, frontline care, and laboratory and diagnostics categories.

    This is gloves, wound care, procedure trays, diagnostics, textiles, infection-control products, and the supply-chain muscle to move all of it where it needs to go.

    In December 2025, Medline completed an upsized IPO at $29.00 per share, including the full exercise of the underwriters’ option.

    That is a serious move in a short amount of time.

    So why would smart money care?

    Because Medline sits in one of those attractive middle grounds: it is essential enough to be durable, operationally complex enough to build a moat, and newly public enough that the market may still be figuring out how to value it. The products may not be glamorous. But hospitals, surgery centers, and nursing facilities do not get to “pause” these purchases because the economy feels moody.

    And for investors, weight matters.

    A fresh IPO with real revenue, a sticky customer base, and broad healthcare exposure is a very different bet than chasing a concept stock with a nice PowerPoint and no operating history.

    SpaceX takes major step toward IPO

    Bloomberg says SpaceX is preparing to file confidentially for an IPO this month.

    That's why I'm claiming my stake right now, months before the IPO.

    This report shows you how you can do the same (email required)

    Which is usually a good sign.

    That’s not a high-drama growth story.

    It’s T-shirts, socks, underwear, fleece, and staples.

    People still buy the boring stuff in good economies and bad ones.

    As of March 6, 2026, the stock was trading around $63.43.

    This is the kind of company that value-oriented investors often like because the business is understandable, the products are everyday necessities, and the earnings power can surprise people who dismiss it as “just apparel.”

    They think exciting equals profitable.

    It just needs a cash register.

    And that’s why it fits on a list like this.

    If you want the newly public healthcare-supplies story with scale and fresh momentum, Medline is the replacement that belongs here.

    If you want the public

    Most pundits are predicting the coming midterm elections will be a disaster for Republicans.

    Could save Trump from this disaster.

    Found this helpful? Share it with others.

    Written by Ian Cooper

    Our Flagship Publication

    Discover Great Companies Trading at a Discount

    Join Behind the Markets